SCYNEXIS, Inc. Weighted Average Number of Shares Outstanding, Basic and Diluted
SCYNEXIS, Inc. (SCYX) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 26.38 million shares for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-29.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2022-03-29
- SCYNEXIS, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-06-30 was 10.01M shares, a 87.88% increase year-over-year.
- SCYNEXIS, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-03-31 was 97.45M shares, a 97.59% increase year-over-year.
- SCYNEXIS, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2019-06-30 was 5.33M shares, a 88.63% decline year-over-year.
- SCYNEXIS, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2019-03-31 was 49.32M shares, a 46.87% increase year-over-year.
- SCYNEXIS, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2021 was 26.38M shares, a 146.12% increase from fiscal 2020.
- SCYNEXIS, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 10.72M shares, a 91.15% increase from fiscal 2019.
- SCYNEXIS, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 5.61M shares, a 87.22% decline from fiscal 2018.
- SCYNEXIS, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2018 was 43.88M shares, a 64.07% increase from fiscal 2017.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2021-12-31 | 26.38M shares 10-K · filed 2022-03-29 | ||||||
| 2020-12-31 | 10.72M shares 10-K · filed 2022-03-29 | ||||||
| 2020-06-30 | 10.01M shares 10-Q · filed 2020-08-10 | 9.88M shares 10-Q · filed 2020-08-10 | |||||
| 2020-03-31 | 97.45M shares 10-Q · filed 2020-05-11 | ||||||
| 2019-12-31 | 5.61M shares 10-K · filed 2021-03-29 | 56.08M shares 10-K · filed 2020-03-11 | |||||
| 2019-06-30 | 5.33M shares 10-Q · filed 2020-08-10 | 53.28M shares 10-Q · filed 2019-08-07 | 5.13M shares 10-Q · filed 2020-08-10 | 51.31M shares 10-Q · filed 2019-08-07 | |||
| 2019-03-31 | 49.32M shares 10-Q · filed 2020-05-11 | ||||||
| 2018-12-31 | 43.88M shares 10-K · filed 2020-03-11 | ||||||
| 2018-06-30 | 46.84M shares 10-Q · filed 2019-08-07 | 40.25M shares 10-Q · filed 2019-08-07 | 36.37M shares derived: average of 3 quarters · filed 2019-08-07 | 34.05M shares derived: average of 4 quarters · filed 2019-08-07 | |||
| 2018-03-31 | 33.58M shares 10-Q · filed 2019-05-08 | 31.14M shares derived: average of 2 quarters · filed 2019-05-08 | 29.79M shares derived: average of 3 quarters · filed 2019-05-08 | 28.80M shares derived: average of 4 quarters · filed 2019-05-08 | |||
| 2017-12-31 | 28.70M shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | 27.89M shares derived: average of 2 quarters · filed 2019-03-14 | 27.20M shares derived: average of 3 quarters · filed 2019-03-14 | 26.75M shares 10-K · filed 2019-03-14 | |||
| 2017-09-30 | 27.09M shares 10-Q · filed 2017-11-07 | 26.45M shares derived: average of 2 quarters · filed 2018-08-09 | 26.10M shares 10-Q · filed 2017-11-07 | ||||
| 2017-06-30 | 25.81M shares 10-Q · filed 2018-08-09 | 25.59M shares 10-Q · filed 2018-08-09 | |||||
| 2016-12-31 | 24.15M shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-13 | 23.79M shares derived: average of 2 quarters · filed 2018-03-13 | 20.72M shares derived: average of 3 quarters · filed 2018-03-13 | 19.04M shares 10-K · filed 2018-03-13 | |||
| 2016-09-30 | 23.43M shares 10-Q · filed 2017-11-07 | 19.01M shares derived: average of 2 quarters · filed 2017-11-07 | 17.33M shares 10-Q · filed 2017-11-07 | ||||
| 2016-06-30 | 14.59M shares 10-Q · filed 2017-08-08 | 14.25M shares 10-Q · filed 2017-08-08 | |||||
| 2016-03-31 | 13.91M shares 10-Q · filed 2016-05-09 | ||||||
| 2015-09-30 | 13.90M shares 10-Q · filed 2016-11-07 | 13.08M shares derived: average of 2 quarters · filed 2016-11-07 | 11.58M shares 10-Q · filed 2016-11-07 | ||||
| 2015-06-30 | 12.25M shares 10-Q · filed 2016-08-08 | 10.39M shares 10-Q · filed 2016-08-08 | |||||
| 2015-03-31 | 8.52M shares 10-Q · filed 2016-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |